KYMRIAH and Yescarta | GILD Message Board Posts

Gilead Sciences, Inc.

  GILD website

GILD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  11843 of 11851  at  2/1/2019 8:55:01 PM  by

spaddy


 In response to msg 11838 by  captsolo
view thread

Re: KYMRIAH and Yescarta

 given the vast numbers of trials GILD is doing they seem to be trying to lock up the CD19 CART market..and they already making gen 2 versions for CD19 also to keep its lead..
 
From a marketing perspective seems like GILD will be the go to company for leukemia/lymphoma CART drugs..
 
Will probably also help for recruiting for new trials since they will have credibility with all the hematology centers 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 167
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...